SMC5/6-Related Primordial Dwarfism and Associated Metabolic Complications: A Review of Genome Instability and Adipose Tissue Dysfunction.
文献摘要
Background The structural maintenance of chromosomes (SMC) 5/6 complex is a key regulator of genomic integrity, with major roles in DNA damage repair, recovery from replication stress, and maintenance of chromosome stability. To date, only a small number of patients with primordial dwarfism caused by pathogenic variants in NSMCE2 or SMC5 have been reported. Some affected individuals exhibit metabolic abnormalities, including reduced adipose tissue, severe insulin resistance, dyslipidemia, diabetes, and hepatic steatosis, although the phenotypic spectrum varies considerably across different variants. Objective To comprehensively evaluate the potential links among genomic instability, adipose tissue dysfunction, and metabolic complications in SMC5/6-related primordial dwarfism, compare the strength of evidence supporting different candidate mechanisms, and define the current boundaries of evidence and major gaps in knowledge. Sources of data PubMed/MEDLINE and the Web of Science Core Collection were searched from database inception through March 2026, supplemented by reference-list screening and forward citation tracking to identify potentially relevant studies not captured by the primary search. Eligible evidence included human clinical and genetic reports, studies using patient-derived cells, and original cellular and animal studies addressing SMC5/6 function, genome maintenance, adipogenesis, metabolic regulation, and growth-related signaling. Content Cells derived from some patients carrying pathogenic NSMCE2 or SMC5 variants exhibit impaired recovery from replication stress, abnormal DNA damage responses (DDR), and chromosomal instability. Cellular and animal models further indicate that SMC5 dysfunction can be accompanied by activation of p53 signaling, impaired mitotic clonal expansion(MCE), defective adipogenic differentiation of preadipocytes, and metabolic abnormalities. Among the proposed mechanisms, the link between DDR-p53-related stress and impaired preadipocyte expansion and adipogenesis is supported by relatively strong functional evidence. Reduced adipose tissue development and lipid storage capacity may, in turn, contribute to insulin resistance, hypertriglyceridemia, and hepatic lipid accumulation. NSMCE2, a subunit of the SMC5/6 complex with SUMO E3 ligase activity, has also been implicated in the regulation of PPARα protein stability and hepatic lipid metabolism, while potential interactions between SMC5/6 and IGF-AKT signaling have been proposed. However, these associations remain context-dependent candidate mechanisms and have not yet been established in inherited SMC5/6 deficiency. Conclusions SMC5/6-related primordial dwarfism provides an informative rare-disease model for investigating the interplay among genome maintenance, growth and development, and metabolic homeostasis. Current evidence supports a layered mechanistic framework centered on genomic stress and adipose tissue dysfunction, but human data remain very limited and are insufficient to establish a general role for SMC5/6 in common metabolic diseases. Whether this framework extends to prevalent disorders such as type 2 diabetes, obesity, and metabolic dysfunction-associated steatotic liver disease (MASLD) requires independent validation.